Medical Oncology

Uveitis and Ocular Immunology

Questions discussed in this category

How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?

1 Answer available

How do you manage MEK inhibitor induced ocular adverse events?

1 Answer available

Papers discussed in this category

JAMA ophthalmology, 2016-08-01

Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic Cancer.

Related Topics in Medical Oncology